Eikon Therapeutics Appoints Ching-Pin Chang as Chief Scientific Officer
Position
Executive Vice President
Company
Eikon Therapeutics
MillbraeBiotechnologyHealth CareTherapeuticsDescription
Eikon Therapeutics has announced the appointment of Ching-Pin Chang, M.D., Ph.D. as Executive Vice President and Chief Scientific Officer. Dr
Quick answer
Eikon Therapeutics Appoints Ching-Pin Chang as Chief Scientific Officer (September 3, 2026). Eikon Therapeutics is based in Millbrae, California, United States.
- Who is the new Executive Vice President at Eikon Therapeutics?
- Eikon Therapeutics named Ching-Pin Chang Executive Vice President, announced September 3, 2026.
- What did Eikon Therapeutics announce on September 3, 2026?
- Eikon Therapeutics has announced the appointment of Ching-Pin Chang, M.D., Ph.D. as Executive Vice President and Chief Scientific Officer.
- Where did Ching-Pin Chang work before joining Eikon Therapeutics?
- Ching-Pin Chang joins from Bristol Myers Squibb.
- What does Eikon Therapeutics do?
- Eikon Therapeutics is advancing breakthrough therapies through the purposeful integration of science and engineering.
- Where is Eikon Therapeutics based?
- Eikon Therapeutics is based in Millbrae, California, United States.
- Which similar companies made leadership changes around the same time?
- Priothera (September 3, 2026), Vaxcyte, Inc. (September 3, 2026), Foventa Therapeutics (September 2, 2026) and Allogene Therapeutics, Inc. (September 2, 2026) also announced leadership changes within 45 days of Eikon Therapeutics.
Source: Fundz verified event record.
Other recent leadership changes in Therapeutics and Biotechnology
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- Priothera Appoints Nigel Clark as Chief Business Officer (September 3, 2026)
- Vaxcyte Appoints Luis Jodar as Chief Medical Officer and David McAvoy as Chief Legal Officer (September 3, 2026)
- Foventa Therapeutics Appoints Dr Zaiba Malik as Chief Medical Officer and Julia Jones as Chief Financial Officer (September 2, 2026)
- Allogene Therapeutics Announces Retirement of CFO Geoffrey Parker (September 2, 2026)
- Vertex Pharmaceuticals Appoints Jonathan Poole as Chief Financial Officer (September 2, 2026)
- Arletta Pharma Solutions Appoints Jeannette Jager-van Dijk as Chief Executive Officer (September 1, 2026)
Who to call at Eikon Therapeutics, and when
A new leader at Eikon Therapeutics brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Eikon Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Eikon Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Eikon Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Eikon Therapeutics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Eikon Therapeutics changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.